http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2219938-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1989-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dd4533fb55e381d9cdd8182a48e3683
publicationDate 1989-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2219938-A
titleOfInvention Use of a thromboxane receptor antagonist in pregnancy-induced hypertension
abstract The use of a compound of formula (1> <IMAGE> wherein R<1> is a H or methyl; X is cis or trans -CH=CH- or -CH2CH2-, m is 2, 3 or 4 and n is 1; or X is trans -CH=CH-, m is zero and n is 3; Y is a saturated heterocyclic amino group (attached to the cyclopentane ring via the nitrogen atom) which a has 5-8 ring members; Alk is a straight or branched C1-5 alkyl; l is zero or 1; p is zero, 1, 2, 3 or 4; R<2> is OH, -OCOR<3>, -CO2R<3>, -CONR<3>R<4>, -SO2NR<3>R <4, -NHCOR<3>, -NH3, -NHSO2R<5>, -SO2R<5>, -SR<5>, -NR<3>R<4>, -COR<5>, NHCONR<3>R<4> or -NHCSNH2; R<3>, and R<3a>and R<4> are each H or a C1-4 alkyl or C7-10 aralkyl group; and R<5> is a C1-4 alkyl group; or a physiologically acceptable salt, solvate or cyciodextrin complex thereof in the manufacture of medicaments for the therapy or prophylaxis of conditions associated with vasoconstriction and/or platelet aggregation in the uteroplacental circulation and/or excessive synthesis of thromboxane A2 in a pregnant female subject.
priorityDate 1988-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0296802-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1385867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID214728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422944431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5249138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3614769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21490868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452407714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426123532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153769331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421222743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54694259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429244960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415878202

Total number of triples: 44.